Bio Path Holdings Inc reports results for the quarter ended September 30 - Earnings Summary

Bio Path Holdings

15/11/2024 14:31

* Bio Path Holdings Inc  BPTH.OQ  reported a quarterly
adjusted
loss of 70 cents​​ per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of $-6.40.  The lone analyst forecast for the
quarter was for a loss of $1.02 per share. 
    * Reported revenue was zero​; analysts expected zero. 
    * Bio Path Holdings Inc's reported EPS for the quarter was a
loss
of 70 cents​.
    * The company reported a quarterly loss of $2.12 million.
    * Bio Path Holdings Inc shares had fallen by 1.1% this
quarter and
lost 90.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Bio Path Holdings
Inc is $20.00 
This summary was machine generated from LSEG data November 15 at
02:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -1.02          -0.70          Beat
 Jun. 30 2024      -1.54          -1.16          Beat
 Mar. 31 2024      -4.54          -4.88          Missed
 Dec. 31 2023      -5.40          -7.05          Missed